Jul 29, 2022

Featuring perspectives from Prof Ghassan Abou-Alfa, including the following topics:

• Introduction (0:00)
• Case: A woman in her early 50s with metastatic hepatoid carcinoma of the ovary with an FGFR fusion — Syed M Ahmed, MD, PhD (2:56)
• Key recent data sets (5:59)
• Case: A man in his mid 60s with a history of Child-Pugh...

Jul 28, 2022

Featuring a slide presentation and related discussion from Dr Sandy Srinivas, including the following topics:

• Results from the Phase II SALV-ENZA trial evaluating salvage radiation therapy with enzalutamide or placebo for high-risk PSA-recurrent prostate cancer after radical prostatectomy (0:00)
• Updated overall...

Jul 28, 2022

Featuring an interview with Dr Sandy Srinivas, including the following topics:

• Rationale for and efficacy data from the Phase II SALV-ENZA trial of salvage radiation therapy with enzalutamide or placebo for high-risk recurrent hormone-sensitive prostate cancer (0:00)
• Results from clinical trials evaluating abiraterone,...

Jul 27, 2022

Featuring perspectives from Dr Richard Stone, including the following topics:

• Introduction: RATIFY trial in perspective (0:00)
• Treatment with FLT3 inhibitors (7:00)
• Anti-CD47 antibody: Magrolimab (23:04)
• Anti-TIM-3 antibody: Sabatolimab (31:23)
• CAR T-cell therapy for acute myeloid leukemia (34:53)
• Targeted therapy with...

Jul 22, 2022

Featuring perspectives from Dr Christopher Flowers and Ms Robin Klebig, including the following topics:

• Management of Diffuse Large B-Cell Lymphoma (0:00)
• Caring for Patients with Hodgkin Lymphoma (32:59)
• Treatment for Follicular Lymphoma (44:17)
• Managing Mantle Cell Lymphoma (58:12)

NCPD information and select...